ICPA Introduces ‘Trioplast’ – Oral Anti-Ulcer Dental Paste For Mouth Ulcers

Mumbai, August 2022: ICPA Health Products Ltd (ICPA), India’s leading pharmaceutical company and pioneers in the oral-health segment has introduced its latest offering – Trioplast, an oral anti-ulcer dental paste for treating mouth ulcers. When applied on the site of lesion inside the mouth, the paste provides relief from swelling and redness in the affected area. Mouth ulcers are painful sores that develop inside the mouth which typically affects an individual’s ability to eat, drink or even talk. Triamcinolone acetonide, the main chemical in the paste helps stop or lower the irritation and swelling in the mouth by reducing reaction to the allergen.

ICPA’s Trioplast is indicated for inflammatory disorders of the mouth, desquamative gingivitis; lesions of oral mucosa, mucositis, oral sub-mucous fibrosis, recurrent aphthous ulcers, stomatitis and ulcerative conditions associated with pemphigus, pemphigoid, etc.

Directions for use: – Squeeze out about one-fourth of an inch long ribbon of Trioplast on the tip of a clean and dry finger. Apply with little pressure to the lesion until a thin film develops and hold in position until it becomes sticky. The paste should be applied at bedtime to permit steroid contact with the lesion throughout the night. Depending on the severity of symptoms, it may be necessary to apply the preparation two to four times a day, preferably after meals. Do not eat or drink for half an hour after applying.

Trioplast 0.1% oral paste is supplied in a 5g laminated tube containing 1mg of triamcinolone acetonide per gram of paste.

Company name: ICPA Health Products

Product name: Trioplast

Comments are closed.